Filing Details
- Accession Number:
- 0001209191-18-062263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-12 17:21:24
- Reporting Period:
- 2018-12-10
- Accepted Time:
- 2018-12-12 17:21:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1666071 | Cardlytics Inc. | CDLX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1617486 | D. Scott Grimes | C/O Cardlytics, Inc. 675 Ponce De Leon Avenue Ne, Suite 6000 Atlanta GA 30308 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-10 | 75,000 | $0.00 | 650,710 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-10 | 12,900 | $13.69 | 637,810 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-11 | 14,452 | $13.32 | 623,358 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-12 | 1 | $13.71 | 623,357 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Stock Unit | Disposition | 2018-12-10 | 75,000 | $0.00 | 75,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 800 | Indirect | By immediate family member |
| Common Stock | 194,112 | Indirect | See Footnote |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock.
- Includes 1,923 shares of the Common Stock acquired under the Issuer's Employee Stock Purchase Plan.
- Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.30 - $14.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.15 - $13.61, inclusive.
- The reportable securities are held by the 2013 Scott Grimes GRAT UAD (the "GRAT"). The Reporting Person is the trustee of the GRAT.
- The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs").
Billionaire Hedge Funds
